Dr. Schwartzberg’s research interests focus on breast cancer, supportive care, precision medicine and patient reported outcomes. He is Chief, Medical Oncology and Hematology at the at the William N. Pennington Cancer Institute at Renown Health and Professor of Clinical Medicine, University of Nevada School of Medicine Reno. He has published over 300 peer reviewed manuscripts, book chapters and monographs. He is founding editor in chief of the Elsevier website Practice Update Oncology and founding editor in chief of the journal Community Oncology. Dr. Schwartzberg was honored as the 2023 Legends in Cancer honoree at the Best of Breast conference for his contributions to the field of breast cancer.
Dr. Boccia focuses on cutting-edge drug development. He is Medical Director of the Center for Cancer and Blood Disorders in Bethesda, Maryland, where he has up to 60 clinical trials at all times, and 10 FTEs for research. He is also Clinical Associate Professor of Medicine at Georgetown University in Washington, DC. and serves as the Chief Medical Officer for the International Oncology Network (ION). He is a member of numerous professional societies including ASCO, ASH and the American College of Physicians.
Dr. VanderWalde specializes in melanoma and is experienced in genomic tumor assessment, public health, tumor immunotherapy, medical ethics and precision oncology. He is the Global Head of Clinical Research at Caris Life Sciences and works as Research Faculty at West Cancer Center where he served as the Director of Research from 2014 to 2021. He is also Professor in the Division of Epidemiology at the University of Memphis School of Public Health. Dr. VanderWalde has extensive experience in clinical research, including the design and conduct of clinical trials, results reporting, regulatory filing and interactions between investigators and the pharmaceutical industry.
Dr. Loong’s research focuses on sarcoma medical oncology, neuro-oncology, thoracic oncology and experimental therapeutics (Phase I trials). Based in Hong Kong, he holds conjoint appointments of Clinical Associate Professor, Department of Clinical Oncology and Deputy Medical Director, Phase I Clinical Trials Centre, The Chinese University of Hong Kong. He is the current and founding convenor, the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team. He has conducted >50 oncology trials as Principal Investigator or Co-Investigator. Dr. Loong is a founding executive committee member of the Asia Pacific Oncology Drug Development Consortium and Chair-Elect, International Affairs Committee at ASCO.
Dr. Pluard’s research focuses on novel therapies in metastatic breast cancer. He is Medical Director at Luke’s Cancer Institute and Founding Director of Saint Luke’s Koontz Center for Advanced Breast Cancer, Kansas City. Previously, he was Associate Professor of Medicine and Clinical Director of Breast Oncology at Washington University Siteman Cancer Center, St. Louis. His clinical focus is exclusively metastatic breast cancer care including advanced genomic and immunotherapy treatments, and he is a major contributor to numerous clinical trials. Saint Luke’s Cancer Institute has the region’s largest portfolio of Stage 4 breast cancer clinical trials―through partnerships, access to >200 trials.
Dr. Chandler focuses on blood cancers with a specific focus of cellular therapy in multiple myeloma and lymphoma. He heads up malignant hematology research at West Cancer Center in Memphis, TN. He spent five years as a member of the NCCN guidelines committee for multiple myeloma and is involved in multiple clinical trials ranging from Phase I to III in malignant hematology. Dr. Chandler has been involved with building a stem cell transplant/CAR-T program and is currently doing so again with a focus on out-patient administration.
Meet with George Clinical! Contact us to schedule a time now.